Literature DB >> 23186391

Quantification of amyloid precursor protein isoforms using quantification concatamer internal standard.

Junjun Chen1, Meiyao Wang, Illarion V Turko.   

Abstract

It is likely that expression and/or post-translational generation of various protein isoforms can be indicative of initial pathological changes or pathology development. However, selective quantification of individual protein isoforms remains a challenge, because they simultaneously possess common and unique amino acid sequences. Quantification concatamer (QconCAT) internal standards were originally designed for a large-scale proteome quantification and are artificial proteins that are concatamers of tryptic peptides for several proteins. We developed a QconCAT for quantification of various isoforms of amyloid precursor protein (APP). APP-QconCAT includes tryptic peptides that are common for all isoforms of APP concatenated with those tryptic peptides that are unique for specific APP isoforms. Isotope-labeled APP-QconCAT was expressed, purified, characterized, and further used for quantification of total APP, APP695, and amyloid-β (Aβ) in the human frontal cortex from control and severe Alzheimer's disease donors. Potential biological implications of our quantitative measurements are discussed. It is also expected that using APP-QconCAT(s) will advance our understanding of biological mechanism by which various APP isoforms involved in the pathogenesis of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23186391      PMCID: PMC4009702          DOI: 10.1021/ac3033239

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  19 in total

1.  Serum clusterin levels are not increased in presymptomatic Alzheimer's disease.

Authors:  Linda IJsselstijn; Lennard J M Dekker; Peter J Koudstaal; Albert Hofman; Peter A E Sillevis Smitt; Monique M B Breteler; Theo M Luider
Journal:  J Proteome Res       Date:  2011-02-22       Impact factor: 4.466

2.  Stoichiometry and absolute quantification of proteins with mass spectrometry using fluorescent and isotope-labeled concatenated peptide standards.

Authors:  Dhaval Nanavati; Marjan Gucek; Jacqueline L S Milne; Sriram Subramaniam; Sanford P Markey
Journal:  Mol Cell Proteomics       Date:  2007-11-19       Impact factor: 5.911

3.  Quantitation of amyloid beta peptides Aβ(1-38), Aβ(1-40), and Aβ(1-42) in human cerebrospinal fluid by ultra-performance liquid chromatography-tandem mass spectrometry.

Authors:  Mary E Lame; Erin E Chambers; Matthew Blatnik
Journal:  Anal Biochem       Date:  2011-08-12       Impact factor: 3.365

4.  Optimizing the conditions of a multiple reaction monitoring assay for membrane proteins: quantification of cytochrome P450 11A1 and adrenodoxin reductase in bovine adrenal cortex and retina.

Authors:  Wei-Li Liao; Gun-Young Heo; Nathan G Dodder; Irina A Pikuleva; Illarion V Turko
Journal:  Anal Chem       Date:  2010-07-01       Impact factor: 6.986

Review 5.  Translating cell biology into therapeutic advances in Alzheimer's disease.

Authors:  D J Selkoe
Journal:  Nature       Date:  1999-06-24       Impact factor: 49.962

6.  Multiplexed absolute quantification in proteomics using artificial QCAT proteins of concatenated signature peptides.

Authors:  Robert J Beynon; Mary K Doherty; Julie M Pratt; Simon J Gaskell
Journal:  Nat Methods       Date:  2005-08       Impact factor: 28.547

7.  Relative increase in Alzheimer's disease of soluble forms of cerebral Abeta amyloid protein precursor containing the Kunitz protease inhibitory domain.

Authors:  R D Moir; T Lynch; A I Bush; S Whyte; A Henry; S Portbury; G Multhaup; D H Small; R E Tanzi; K Beyreuther; C L Masters
Journal:  J Biol Chem       Date:  1998-02-27       Impact factor: 5.157

8.  Measurement of altered AβPP isoform expression in frontal cortex of patients with Alzheimer's disease by absolute quantification real-time PCR.

Authors:  William G Tharp; Yong-Ho Lee; Shane M Greene; Elise Vincellete; Thomas G Beach; Richard E Pratley
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

9.  Strategy combining separation of isotope-labeled unfolded proteins and matrix-assisted laser desorption/ionization mass spectrometry analysis enables quantification of a wide range of serum proteins.

Authors:  Wei-Li Liao; Illarion V Turko
Journal:  Anal Biochem       Date:  2008-03-15       Impact factor: 3.365

10.  Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide.

Authors:  Tadafumi Hashimoto; Alberto Serrano-Pozo; Yukiko Hori; Kenneth W Adams; Shuko Takeda; Adrian Olaf Banerji; Akinori Mitani; Daniel Joyner; Diana H Thyssen; Brian J Bacskai; Matthew P Frosch; Tara L Spires-Jones; Mary Beth Finn; David M Holtzman; Bradley T Hyman
Journal:  J Neurosci       Date:  2012-10-24       Impact factor: 6.167

View more
  7 in total

1.  Mass spectrometry quantification of PICALM and AP180 in human frontal cortex and neural retina.

Authors:  Junjun Chen; Irina A Pikuleva; Illarion V Turko
Journal:  Anal Biochem       Date:  2013-08-13       Impact factor: 3.365

Review 2.  Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases.

Authors:  Eugene M Cilento; Lorrain Jin; Tessandra Stewart; Min Shi; Lifu Sheng; Jing Zhang
Journal:  J Neurochem       Date:  2019-01-31       Impact factor: 5.372

3.  FastCAT Accelerates Absolute Quantification of Proteins Using Multiple Short Nonpurified Chimeric Standards.

Authors:  Ignacy Rzagalinski; Aliona Bogdanova; Bharath Kumar Raghuraman; Eric R Geertsma; Lena Hersemann; Tjalf Ziemssen; Andrej Shevchenko
Journal:  J Proteome Res       Date:  2022-05-13       Impact factor: 5.370

Review 4.  Biomarkers in Alzheimer's disease analysis by mass spectrometry-based proteomics.

Authors:  Yahui Liu; Hong Qing; Yulin Deng
Journal:  Int J Mol Sci       Date:  2014-05-06       Impact factor: 5.923

5.  Quantification of histone deacetylase isoforms in human frontal cortex, human retina, and mouse brain.

Authors:  Kyle W Anderson; Junjun Chen; Meiyao Wang; Natalia Mast; Irina A Pikuleva; Illarion V Turko
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

6.  Histone H3 Ser57 and Thr58 phosphorylation in the brain of 5XFAD mice.

Authors:  Kyle W Anderson; Natalia Mast; Irina A Pikuleva; Illarion V Turko
Journal:  FEBS Open Bio       Date:  2015-06-25       Impact factor: 2.693

Review 7.  Platelets, a reliable source for peripheral Alzheimer's disease biomarkers?

Authors:  Michael Veitinger; Balazs Varga; Sheila B Guterres; Maria Zellner
Journal:  Acta Neuropathol Commun       Date:  2014-06-16       Impact factor: 7.801

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.